Gardner Lewis Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Gardner Lewis Asset Management's EXAS Position: Q1 2026 in Review
Gardner Lewis Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 87,528 shares — an estimated $8.89M sold.
Gardner Lewis Asset Management first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $8.89M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Gardner Lewis Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Gardner Lewis Asset Management sold 87,528 Exact Sciences shares in Q1 2026, an estimated $8.89M.
- Gardner Lewis Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
- Gardner Lewis Asset Management's Exact Sciences position peaked at $8.89M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Gardner Lewis Asset Management's 13F filing for Q1 2026, filed 8 May 2026.